Related Experiment Video
Updated: Jun 19, 2026
08:03
Cervical Lymph Duct-Cannulated Rat Model for Assessing Lymphatic Transport from the Head and Brain
Published on: March 10, 2026
A COMPARATIVE STUDY OF LYMPH AND SERUM FERMENTS DURING PROTEIN SHOCK REACTIONS
1Laboratory of Physiological Chemistry of the College of Medicine of the University of Illinois, Chicago.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Protein shock therapy enhances recovery by increasing lymph flow and antibody concentration in lymph channels, rather than solely serum changes. This mechanism aids in combating bacterial infections within the lymphatic system.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Treatments
Background:
- Protein shock therapy is used to treat infections.
- Recovery mechanisms following protein shock therapy are not fully understood.
- Previous research suggested serum changes are key, but lymph alterations may be more significant.
Purpose of the Study:
- To investigate the role of lymph and serum changes in recovery after protein shock therapy.
- To elucidate the mechanisms by which protein shock therapy combats bacterial infections.
Main Methods:
- Experiments were conducted to observe changes in lymph and serum following protein shock therapy.
- The study focused on the rate of lymph flow and antiferment levels.
- Correlations were drawn between these changes and the body's response to bacterial infections.
Main Results:
- Protein shock therapy increases lymph flow and forces antibody-rich serum into lymph channels.
- A significant increase in antiferment levels within the lymph stream was observed.
- These lymph-centric changes appear crucial for combating bacteria in lymph spaces, unlike infections not confined to these areas.
Conclusions:
- Recovery from infections treated with protein shock therapy is primarily linked to lymph alterations, not just serum changes.
- Increased lymph flow and antiferment concentration in lymph are key factors in inhibiting bacterial growth.
- The findings suggest protein shock therapy is particularly effective against bacteria located within lymph spaces.